NAVB — Navidea Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Navidea Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4.28	1.05	2.67	4.23	2
Net Total Accounts Receivable
Net Total Receivables	0.021	0.901	2.99	0.093	0.001
Total Inventory
Prepaid Expenses
Total Current Assets	5.6	2.92	6.53	5.38	3.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.162	0.312	0.382	0.249	0.156
Net Intangible Assets
Other Long Term Assets
Total Assets	7.02	4.15	7.76	6.64	4.37
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.38	3.82	4.72	5.3	9.94
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	5.28	5.76	6.44	6.75	12.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.74	-1.61	1.32	-0.107	-8.44
Total Liabilities & Shareholders' Equity	7.02	4.15	7.76	6.64	4.37
Total Common Shares Outstanding
Total Preferred Shares Outstanding